Chemotherapy and novel biologics targeting the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) pathways have been the mainstay to treat advanced or metastatic colorectal cancer (mCRC). The gene discussed is VEGFA; the disease is metastatic colorectal cancer.